The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect - EP2992891

The patent EP2992891 was granted to UCB Pharma on Aug 5, 2020. The application was originally filed on Jun 15, 2007 under application number EP15156237A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2992891

UCB PHARMA
Application Number
EP15156237A
Filing Date
Jun 15, 2007
Status
Granted And Under Opposition
Jul 3, 2020
Publication Date
Aug 5, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBMay 3, 2021LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBWITHDRAWN

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2005EP10603
DESCRIPTIONEP1541138
DESCRIPTIONUS5378729
DESCRIPTIONUS5773475
OPPOSITIONWO2006079547

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents